Grajdeanu main and current model she went into discussing was on lupus nephritis and its clinical background. This is inflammation of the kidney caused by systemic lupus erythematous that is an autoimmune and inflammation disease. Its therapies include corticosteroids, immunosuppressive drugs, and medications. Urinary biomarkers are used to test where the disease is coming from and help determine what therapy is best for the patient. Dr. Grajdeanu thought of a solution to integrate biomarkers into a dynamical model of lupus nephritis. She created a model that demonstrates the interaction of biomarkers and other important variables in the disease. She is hoping that in the future the model can be used to make predictions like which patient will flare and when will a patient flare. She wants her model to be understandable to a biologist who does not have a mathematical modeling background. She is still continuing her research with lupus and ended the seminar with a message of keeping in mind that its not how complicated we can make a model but how useful we can make it so that others can use it
Grajdeanu main and current model she went into discussing was on lupus nephritis and its clinical background. This is inflammation of the kidney caused by systemic lupus erythematous that is an autoimmune and inflammation disease. Its therapies include corticosteroids, immunosuppressive drugs, and medications. Urinary biomarkers are used to test where the disease is coming from and help determine what therapy is best for the patient. Dr. Grajdeanu thought of a solution to integrate biomarkers into a dynamical model of lupus nephritis. She created a model that demonstrates the interaction of biomarkers and other important variables in the disease. She is hoping that in the future the model can be used to make predictions like which patient will flare and when will a patient flare. She wants her model to be understandable to a biologist who does not have a mathematical modeling background. She is still continuing her research with lupus and ended the seminar with a message of keeping in mind that its not how complicated we can make a model but how useful we can make it so that others can use it